Variant · Snv
POLE NM_006231.4(POLE):c.154C>T (p.Arg52Trp)
CI-VAR-00044238Explore in graph →p.Arg52TrpNM_006231.4:c.154C>TClinVar 240396 rs115452881
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 240396 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications | 1 | Colorectal cancer, susceptibility to, 12; Facial dysmorphism-immunodeficiency-livedo-short stature syndrome; Hereditary cancer-predisposing syndrome; Hereditary cancer; POLE-related disorder; Familial colorectal cancer type X; Polymerase proofreading-related adenomatous polyposis; Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency | germline | 16 | Jan 21, 2026 | clinvar |